Brandon Holtrup
Private Equity Investor bij Oberland Capital Management LLC
Profiel
Dr. Holtrup is a Vice President at Oberland Capital.
Prior to joining Oberland, Dr. Holtrup was an Associate Director in Global Analytics & Insight (Early Oncology) at AstraZeneca, where he focused on evaluating the commercial potential of early-stage assets.
Previously, Dr. Holtrup was a Consultant at L.E.K.
Consulting, where he provided strategic management advising to pharmaceutical and biotech companies.
Dr. Holtrup completed a PhD at Yale University, focusing on the molecular mechanisms governing metabolism and obesity.
Dr. Holtrup also holds a B.S.
from DePaul University in Biology.
Actieve functies van Brandon Holtrup
| Bedrijven | Functie | Begin |
|---|---|---|
Oberland Capital Management LLC
 Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Private Equity Investor | 01-02-2023 |
Opleiding van Brandon Holtrup
| Yale University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Oberland Capital Management LLC
Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Finance |
